THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 64 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,052,661 | -67.0% | 4,108,796 | +14.6% | 17.63% | -27.8% |
Q2 2023 | $33,451,278 | +5.1% | 3,585,346 | 0.0% | 24.43% | +3.8% |
Q1 2023 | $31,837,872 | +78.3% | 3,585,346 | 0.0% | 23.54% | +69.7% |
Q4 2022 | $17,855,023 | -7.7% | 3,585,346 | +7.5% | 13.87% | -6.8% |
Q3 2022 | $19,345,000 | +4.9% | 3,335,346 | 0.0% | 14.87% | +15.4% |
Q2 2022 | $18,444,000 | -50.2% | 3,335,346 | +3.8% | 12.88% | -14.8% |
Q1 2022 | $37,043,000 | -9.1% | 3,212,732 | 0.0% | 15.13% | +51.1% |
Q4 2021 | $40,737,000 | – | 3,212,732 | – | 10.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 4,108,796 | $11,052,661 | 17.63% |
Omega Fund Management, LLC | 711,479 | $1,913,879 | 1.76% |
Lynx1 Capital Management LP | 702,415 | $1,889,496 | 1.25% |
Orbimed Advisors | 17,713,600 | $47,649,584 | 1.01% |
Nextech Invest Ltd. | 611,310 | $1,644,424 | 0.50% |
Frazier Life Sciences Management, L.P. | 2,248,194 | $6,047,642 | 0.40% |
Affinity Asset Advisors, LLC | 400,726 | $1,077,953 | 0.30% |
DENALI ADVISORS LLC | 127,900 | $344,051 | 0.12% |
Rock Springs Capital Management LP | 437,329 | $1,176,415 | 0.03% |
Forefront Analytics, LLC | 17,672 | $47,539 | 0.03% |